Prognostic Value of Melatonin in Patients with Chronic Obstructive Pulmonary Disease

REVIEW
Andrey V. Budnevsky, Sergey N. Avdeev, Evgeniy S. Ovsyannikov, Karina V. Vostrikova, Sofiya A. Budnevskaya, Avag G. Kitoyan

 
For citation: Budnevsky AV, Avdeev SN, Ovsyannikov ES, Vostrikova KV, Budnevskaya SA, Kitoyan AG. Prognostic Value of Melatonin in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Biomedicine. 2024;14(2):227-230. doi:10.21103/Article14(2)_RA3
 
Originally published June 5, 2024
 

Abstract: 

The article outlines a detailed examination of multiple scientific studies investigating how melatonin affects COPD's advancement and growth. The severity of oxidative stress in COPD, a complex disease with multiple factors, is significantly reduced by melatonin by activating intracellular antioxidants, as suggested by the data acquired. Considering the available data, we can conclude that melatonin has a protective role against oxidative stress in COPD patients in addition to regulating the circadian rhythm.

Keywords: 
COPD • oxidative stress • reactive oxygen species • melatonin
References: 

1. Federal clinical guidelines: Chronic obstructive pulmonary disease. Revision:2023. Available from: https://spulmo.ru/upload/kr/HOBL_2023_draft.pdf?ysclid=lrq75428cz630397288. (In Russian).
2. Morbidity of the population of the Russian Federation by main classes of diseases. Federal State Statistics Service, Official statistics, Healthcare. Available from: https://rosstat.gov.ru/folder/13721. (In Russian).
3.World Health Organization.  Available from: https://www.who.int/ru/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
4.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD. Available from: https://goldcopd.org/wp-content/uploads/2024/01/GOLD-2024_v1.2-11Jan24_W...
5. Białas AJ, Sitarek P, Miłkowska-Dymanowska J, Piotrowski WJ, Górski P. The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease. Oxid Med Cell Longev. 2016;2016:7808576. doi: 10.1155/2016/7808576. Epub 2016 Dec 26. PMID: 28105251; PMCID: PMC5220474.
6. Sundar IK, Yao H, Rahman I. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal. 2013 May 20;18(15):1956-71. doi: 10.1089/ars.2012.4863. Epub 2012 Nov 6. PMID: 22978694; PMCID: PMC3624634.
7. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016 Jul;138(1):16-27. doi: 10.1016/j.jaci.2016.05.011. Epub 2016 May 27. PMID: 27373322.
8. Polverino F, Celli BR, Owen CA. COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulm Circ. 2018 Jan-Mar;8(1):2045894018758528. doi: 10.1177/2045894018758528. PMID: 29468936; PMCID: PMC5826015.
9. Bernardo I, Bozinovski S, Vlahos R. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities. Pharmacol Ther. 2015 Nov;155:60-79. doi: 10.1016/j.pharmthera.2015.08.005. Epub 2015 Aug 19. PMID: 26297673.
10. Saburova AM, Nasyrdzhonova HR, Sharipova HE, Kurbanova MB. Features of free radical oxidation and metabolic activity of vascular endothelium in patients with chronic obstructive pulmonary disease. Avicenna's Bulletin. 2019; 21(1): 38-42. doi: 10.25005/2074-0581-2019-21-1-38-42. (In Russian).
11. Zhao X, Zhang Q, Zheng R. The interplay between oxidative stress and autophagy in chronic obstructive pulmonary disease. Front Physiol. 2022 Sep 26;13:1004275. doi: 10.3389/fphys.2022.1004275. PMID: 36225291; PMCID: PMC9548529.
12. Albano GD, Montalbano AM, Gagliardo R, Profita M. Autophagy/Mitophagy in Airway Diseases: Impact of Oxidative Stress on Epithelial Cells. Biomolecules. 2023 Aug 4;13(8):1217. doi: 10.3390/biom13081217. PMID: 37627282; PMCID: PMC10452925.
13. Atiakshin DA, Shishkina VV, Esaulenko DI,  Ovsyannikov ES. Mast Cells as the Target of the Biological Effects of Molecular Hydrogen in the Specific Tissue Microenvironment. International Journal of Biomedicine. 2022; 12(2):183-187. doi: 10.21103/Article12(2)_RA2
14. Stanojkovic I, Kotur-Stevuljevic J, Milenkovic B, Spasic S, Vujic T, Stefanovic A, Llic A, Ivanisevic J. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. Respir Med. 2011 Oct;105 Suppl 1:S31-7. doi: 10.1016/S0954-6111(11)70008-7. PMID: 22015083.
15.  Arja C, Surapaneni KM, Raya P, Adimoolam C, Balisetty B, Kanala KR. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease. Respirology. 2013 Oct;18(7):1069-75. doi: 10.1111/resp.12118. PMID: 23683270.
16. Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A, Singh SK, Dixit RK. Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease. Scand J Immunol. 2017 Feb;85(2):130-137. doi: 10.1111/sji.12498. PMID: 28256060.
17.  Sotgia S, Paliogiannis P, Sotgiu E, Mellino S, Zinellu E, Fois AG, Pirina P, Carru C, Mangoni AA, Zinellu A. Systematic Review and Meta-Analysis of the Blood Glutathione Redox State in Chronic Obstructive Pulmonary Disease. Antioxidants (Basel). 2020 Nov 18;9(11):1146. doi: 10.3390/antiox9111146. PMID: 33218130; PMCID: PMC7698942.
18. Wiegman CH, Li F, Ryffel B, Togbe D, Chung KF. Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease. Front Immunol. 2020 Sep 2;11:1957. doi: 10.3389/fimmu.2020.01957. PMID: 32983127; PMCID: PMC7492639.
19.  Provotorov VM, Budnevskiĭ AV, Semenkova GG, Shishkina ES. [PROINFLAMMATORY CYTOKINES IN COMBINATION OF CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE]. Klin Med (Mosk). 2015;93(2):5-9. Russian. PMID: 26117912.
20. Budnevsky AV, Malysh EY. [Clinico-Pathogenetic Relationship of Cardiovascular Diseases and Chronic Obstructive Pulmonary Disease]. Kardiologiia. 2017 Apr;57(4):89-93. Russian. PMID: 28762911.
21. Tokmachev RE, Mukhortova MS, Budnevsky AV, Tokmachev E.V., Ovsyannikov ES. Comorbidity of chronic heart failure and chronic obstructive pulmonary disease: features of pathogenesis, clinical and diagnosis. Cardiovascular Therapy and Prevention. 2018; 17 (6): 62-68. Doi: 10.15829/1728-8800-2018-6-62-68. (In Russian).
22. Mazzoccoli G, Kvetnoy I, Mironova E, Yablonskiy P, Sokolovich E, Krylova J, Carbone A, Anderson G, Polyakova V. The melatonergic pathway and its interactions in modulating respiratory system disorders. Biomed Pharmacother. 2021 May;137:111397. doi: 10.1016/j.biopha.2021.111397. Epub 2021 Feb 19. PMID: 33761613.
23. Arushanyan EB. The protective role of melatonin in disorders of cerebral circulation. RMJ. 2010; 18(8): 495-499. (In Russian).
24. Morvaridzadeh M, Nachvak SM, Agah S, Sepidarkish M, Dehghani F, Rahimlou M, Pizarro AB, Heshmati J. Effect of soy products and isoflavones on oxidative stress parameters: A systematic review and meta-analysis of randomized controlled trials. Food Res Int. 2020 Nov;137:109578. doi: 10.1016/j.foodres.2020.109578. Epub 2020 Jul 21. PMID: 33233189.
25. Budnevsky AV, Tsvetikova LN, Ovsyannikov ES, Goncharenko OV. Melatonin: role in the development of chronic obstructive pulmonary disease. Pulmonology. 2016;26(3):372-378. doi: 10.18093/0869-0189-2016-26-3-372-378. (In Russian).
26. Mahalanobish S, Dutta S, Saha S, Sil PC. Melatonin induced suppression of ER stress and mitochondrial dysfunction inhibited NLRP3 inflammasome activation in COPD mice. Food Chem Toxicol. 2020 Oct;144:111588. doi: 10.1016/j.fct.2020.111588. Epub 2020 Jul 30. Erratum in: Food Chem Toxicol. 2024 Feb;184:114408. PMID: 32738376.
27. Ashrafizadeh M, Najafi M, Kavyiani N, Mohammadinejad R, Farkhondeh T, Samarghandian S. Anti-Inflammatory Activity of Melatonin: a Focus on the Role of NLRP3 Inflammasome. Inflammation. 2021 Aug;44(4):1207-1222. doi: 10.1007/s10753-021-01428-9. Epub 2021 Mar 2. PMID: 33651308.
28. Peng Z, Zhang W, Qiao J, He B. Melatonin attenuates airway inflammation via SIRT1 dependent inhibition of NLRP3 inflammasome and IL-1β in rats with COPD. Int Immunopharmacol. 2018 Sep;62:23-28. doi: 10.1016/j.intimp.2018.06.033. Epub 2018 Jun 30. PMID: 29990691.
29. Halvani A, Mohsenpour F, Abadi EEF. Effect of melatonin on sleep quality of chronic obstructive pulmonary disease (COPD) patients. Eur Respir J 2012; 40: Suppl. 56, 3477
30. Tsvetikova LN, Goncharenko OV, Budnevsky AV, Ovsyannikov ES, Belov VN, Kudashova EA, Shkatova YS. Melatonin in treatment of sleep disorders in elderly patients with chronic obstructive pulmonary disease. International Journal of Biomedicine. 2017;7(2):108-110. doi: 10.21103/Article7(2)_OA4
31. Budnevsky AV, Isaeva YV, Malysh EY, Kozhevnikova SA. [Pulmonary rehabilitation as an effective method for optimizing therapeutic and preventive measures in patients with chronic obstructive pulmonary disease concurrent with metabolic syndrome]. Ter Arkh. 2016;88(8):25-29. Russian. doi: 10.17116/terarkh201688825-29. PMID: 27636923.

Download Article
Received April 17, 2024.
Accepted May 27 2024.
©2024 International Medical Research and Development Corporation.